logo
Select company
Select metric
$ 29.96MNon-Current Liabilities
VS
Market
64
Sector
46
Industry
35
History
12
$ 2.28Close
$ 0.9 - $ 3.27 52-Week Range
Ticker Information

Ticker

ABOS

Company Name

ACUMEN PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ACUMEN PHARMACEUTICALS INC - Non-Current Liabilities Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABOS - LiabilitesNC Historical data
DateNon-Current Liabilities
6/30/2025$ 29.96M
3/31/2025$ 29.64M
12/31/2024$ 29.57M
9/30/2024$ 29.86M
6/30/2024$ 29.6M
3/31/2024$ 30.46M
12/31/2023$ 30.18M
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ACUMEN PHARMACEUTICALS INC's latest trailing twelve months (TTM) LiabilitesNC stands at $ 0.
  • Over the past 5 years, ACUMEN PHARMACEUTICALS INC's average LiabilitesNC has been $ 11.63M.
  • The median LiabilitesNC for ACUMEN PHARMACEUTICALS INC during this period was $ 12.5K
  • ACUMEN PHARMACEUTICALS INC reached its highest LiabilitesNC over the past 5 years at $ 30.46M.
  • The lowest LiabilitesNC recorded by ACUMEN PHARMACEUTICALS INC in the same timeframe $ 0

Definition of Non-Current Liabilities

[Balance Sheet] The non-current (long-term) portion of [Liabilities] includes obligations that are due to be paid to creditors more than year in the future, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]

ABOS - Non-Current Liabilities, Last 5 years

$ 0

Minimum

Mar 31, 2021

$ 30.46M

Maximum

Mar 31, 2024

$ 11.63M

Average

$ 12.5K

Median

LiabilitesNC Benchmark Analysis

The chart above depicts the distribution of LiabilitesNC for companies in the Total Stock Market. The average LiabilitesNC of the companies is $ 126.16M with a standard deviation of $ 195.44M.
The following table provides additional summary stats:
LiabilitesNC in the Market:
filtered constituents2.54K
min$ 0
max$ 831.92M
average$ 126.16M
median$ 24.38M
std$ 195.44M